Targeting of the central histaminergic system for treatment of obesity and associated metabolic disorders
Author:
Publisher
Wiley
Subject
Drug Discovery
Reference120 articles.
1. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor
2. Highly potent and selective ligands for histamine H3-receptors
3. Leptin enters the brain by a saturable system independent of insulin
4. Drug Induced Weight Gain, an Impediment to Successful Pharmacotherapy: Focus on Antipsychotics
5. Weight gain
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Histamine H3 Receptor as a Therapeutic Drug Target for Metabolic Disorders: Status, Challenges and Opportunities;Current Topics in Medicinal Chemistry;2011-06-01
2. Molecular modeling and QSAR-based design of histamine receptor ligands;Expert Opinion on Drug Discovery;2009-09-13
3. 5-Hydroxyindole-2-carboxylic Acid Amides: Novel Histamine-3 Receptor Inverse Agonists for the Treatment of Obesity;Journal of Medicinal Chemistry;2009-05-20
4. The effects of triple therapy (acupuncture, diet and exercise) on body weight: a randomized, clinical trial;International Journal of Obesity;2009-03-10
5. Obesity;The Third Histamine Receptor;2008-11-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3